← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE TABLETS FOR ORAL SUSPENSION

NDA · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2010-02-24

Drug application

FDA Application #

NDA022299

Application type

New Drug Application

Brand name

NEVIRAPINE TABLETS FOR ORAL SUSPENSION

Generic name

Nevirapine

Active ingredients

NEVIRAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

AUROBINDO PHARMA LTD

First approval

2010-02-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown